Delivery Order SPE2DB22D9251-SPE2DB24FR1JV

Award Date 7/15/24
Potential Completion Date 8/5/24
Potential Value $23K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $3,691.84 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for 100-unit vials of the drug Botox, with a performance period through July 12, 2024. This delivery order falls under a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which allows the DLA to issue firm fixed-price...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $23,074.00, is to provide 100-unit vials of the drug Botox. The delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which allows the DLA to issue delivery orders for a wide range of...
This is a $64,685.00 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of 200-unit vials of Botox to support the recurring medical supply needs of military health facilities worldwide. This delivery order is issued under DMS Pharmaceutical Group's single-award indefinite delivery contract (IDC) with the DLA,...
This is a $7,762.20 firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA). The order is for the provision of 200-unit vials of Botox, a branded pharmaceutical product, to support the recurring medical supply needs of military health facilities. The delivery order was issued under DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued at up to...
The U.S. Defense Logistics Agency (DLA) awarded a $8,306.64 firm-fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 100-unit vials of Botox. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract 4600082013 between DMS Pharmaceutical Group and DLA, valued up to $4,999,999 through 2025. The IDV enables DLA to issue delivery orders for a broad range of pharmaceutical products to support the recurring medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,293.72 firm fixed-price delivery order is for the supply of 200-unit vials of Botox. It was awarded under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with DLA valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows DLA to issue delivery orders for...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $11,537.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4565933217 units of BOTOX 100 UNIT VIALS to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical...
This $10,555.92 firm fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA). The contract is for the delivery of 4,557,407,678 units of 100-unit vials of Botox over the period ending June 22, 2022. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue firm fixed-price delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,836.20 contract is for the delivery of 200-unit vials of Botox medication to support the recurring medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,481.60 delivery order is for 100-unit vials of Botox, a specialized pharmaceutical product. The delivery order was awarded under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $499,999,999 and valid through November 2026. This IDC enables...
  • SPE2DB22D9251
    Indefinite Delivery Contract
  • SPE2DB22D9251-SPE2DB24FR1JV
    Delivery Order

This is a $23,074 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The order is for the supply of 100-unit vials of the drug BOTOX. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, that allows the DLA to issue orders for a comprehensive range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. The IDC has no set-aside designation, and DMS Pharmaceutical Group's status as a woman-owned small business has enabled it to secure this direct award for pharmaceutical Prime Vendor programs supporting the Department of Defense.

Generated 10/14/24, 10:05 AM